We are live on ! Find out more
MLSS icon

Milestone Scientific

0.4808 USD
+0.0105
2.23%
At close Updated Aug 21, 4:00 PM EDT
Pre-market
After hours
0.4702
-0.0106
2.2%
1 day
2.23%
5 days
-1.88%
1 month
16.7%
3 months
23.31%
6 months
86.5%
Year to date
63.15%
1 year
-19.04%
5 years
-69.38%
10 years
-80.69%
 

About: Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Employees: 15

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
Seeking Alpha
9 days ago
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
9 days ago
Milestone Scientific Reports Financial Results for Second Quarter 2026
Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales ROSELAND, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) --  Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three and six months ended June 30, 2026.
Milestone Scientific Reports Financial Results for Second Quarter 2026
Neutral
GlobeNewsWire
17 days ago
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company's financial results for the second quarter ended June 30, 2026, as well as the company's corporate progress and other developments.
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
Neutral
GlobeNewsWire
19 days ago
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
Neutral
GlobeNewsWire
1 month ago
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
Neutral
GlobeNewsWire
1 month ago
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside Board Member and ASPN Co-Founder and Vice Chairman, Dr. Dawood Sayed ROSELAND, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced preliminary, unaudited revenue for the second quarter ending June 30, 2026.
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
Neutral
GlobeNewsWire
1 month ago
Milestone Scientific Strengthens Board to Support Next Phase of Growth
ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a series of strategic governance initiatives designed to support the Company's continued evolution and long-term growth.
Milestone Scientific Strengthens Board to Support Next Phase of Growth
Neutral
GlobeNewsWire
2 months ago
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued growth in clinical adoption and physician acceptance of its CompuFlo® Epidural System following the publication of new peer-reviewed research from the University of Texas Medical Branch (UTMB).
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
Neutral
Seeking Alpha
3 months ago
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
3 months ago
Milestone Scientific Reports Financial Results for First Quarter 2026
Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.
Milestone Scientific Reports Financial Results for First Quarter 2026
Price charts implemented using Lightweight Charts™